Treatment of Resistant/Relapsing Chronic Lymphocytic Leukemia with a Combination Regimen Containing Deoxycoformycin and Rituximab

Publisher： Karger

E-ISSN： 1421-9662|111|4|185-188

ISSN： 0001-5792

Source： Acta Haematologica, Vol.111, Iss.4, 2004-05, pp. : 185-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemia

By Wiernik Peter H.   Adiga Giridhar U.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1987-1993

Informa Healthcare

Access to resources Recommend Favorite

Ofatumumab for the treatment of chronic lymphocytic leukemia

By Robak Tadeusz  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 577-587

Future Medicine

Access to resources Recommend Favorite

COMBINATION REGIMEN IN THE TREATMENT OF CHRONIC PROSTATITIS

By Chen W.-M.   Yang C.-R.   Ou Y.-C.   Ho H.-C.   Su C.-K.   Chiu K.-Y.   Cheng C.-L.  

Archives of Andrology, Vol. 52, Iss. 2, 2006-03 ,pp. : 117-121

Informa Healthcare

Access to resources Recommend Favorite

Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : 204-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fludarabine, cyclophosphamide, and multiple‐dose rituximab as frontline therapy for chronic lymphocytic leukemia

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3869-3876

John Wiley & Sons Inc

Access to resources Recommend Favorite